Pfizer (PFE)

Total Costs & Expenses

$47.72B

TTM · Period ending: · USD

PFE logo

PFE Total Costs & Expenses

Latest reported$47.72B
PFE TTM Total Costs & Expenses (-$3.52B → $47.72B)
High-resolution chart · PNG

PFE total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
47,720,000,000
48,470,000,000
47,142,000,000
45,311,000,000
44,941,000,000
45,267,000,000
46,496,000,000
50,291,000,000
54,054,000,000
53,306,000,000
54,787,000,000
57,896,000,000
54,338,000,000
58,477,000,000
62,294,000,000
63,910,000,000
67,256,000,000
65,372,000,000
59,459,000,000
49,614,000,000
41,106,000,000
35,548,000,000
32,822,000,000
32,753,000,000
34,287,000,000
35,995,000,000
37,635,000,000
37,712,000,000
37,803,000,000
38,145,000,000
38,384,000,000
38,882,000,000
38,767,000,000
38,387,000,000
38,156,000,000
38,017,000,000
38,099,000,000
38,430,000,000
38,776,000,000
39,482,000,000
38,261,000,000
37,079,000,000
35,873,000,000
34,927,000,000
35,477,000,000
36,047,000,000
36,105,000,000
35,145,000,000
34,873,000,000
34,634,000,000
36,080,000,000
37,559,000,000
38,854,000,000
40,070,000,000
41,398,000,000
43,331,000,000
45,495,000,000
48,186,000,000
50,077,000,000
51,988,000,000
54,335,000,000
54,392,000,000
54,693,000,000
52,600,000,000
45,825,000,000
40,834,000,000
34,553,000,000
29,725,000,000
30,419,000,000
31,724,000,000
33,262,000,000
35,274,000,000
38,282,000,000
38,402,000,000
38,082,000,000
37,794,000,000
35,048,000,000
34,383,000,000
34,854,000,000
34,802,000,000
34,847,000,000
35,652,000,000
36,375,000,000
36,649,000,000
36,598,000,000
36,216,000,000
34,670,000,000
35,815,000,000
37,306,000,000
36,749,000,000
34,404,000,000
26,905,000,000
22,534,000,000
19,886,000,000
20,096,000,000
22,489,000,000
22,021,000,000
21,667,000,000
21,283,000,000
20,825,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.